180 Life Sciences Corp. Files 8-K: Agreements, Equity Sales, Officer Changes
Ticker: FRMM · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-securities, officer-changes
Related Tickers: ATNF
TL;DR
180 Life Sciences Corp. filed an 8-K detailing new agreements, equity sales, and board changes.
AI Summary
On July 31, 2025, 180 Life Sciences Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and disclosed changes in its board of directors and officer appointments, including compensatory arrangements. The filing also includes information on Regulation FD disclosures and other events.
Why It Matters
This 8-K filing indicates significant corporate actions by 180 Life Sciences Corp., including new agreements and potential equity dilution, which could impact investors.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes lead to dilution and increased risk for existing shareholders.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Filer of the 8-K report
- July 31, 2025 (date) — Earliest event reported date
FAQ
What type of material definitive agreement did 180 Life Sciences Corp. enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What was the date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 31, 2025.
What other items are covered in this 8-K filing besides the material definitive agreement?
This 8-K filing also covers unregistered sales of equity securities, departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD disclosure, and other events.
What is the SIC code for 180 Life Sciences Corp.?
The Standard Industrial Classification (SIC) code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
What was the former name of 180 Life Sciences Corp.?
The former name of 180 Life Sciences Corp. was KBL Merger Corp. IV, with a date of name change on November 15, 2016.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding 180 Life Sciences Corp. (FRMM).